MDK-ERBB3 Fusion FISH Probe
The MDK-ERBB3 Fusion FISH Probe is used to confirm a fusion of the MDK and ERBB3 genes. The fusion of the MDK and ERBB3 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
MDK-ERBB3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-RERE | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-REOR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-REGO | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-REGR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-REAQ | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-ORRE | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-OROR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-ORGO | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-ORAQ | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GORE | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GOOR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GOGO | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GOGR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GOAQ | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GRRE | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GROR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GRGO | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GRGR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-GRAQ | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-AQRE | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-AQOR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-AQGO | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-AQGR | 20 (40 μL) | 200 μL | ||
MDK-ERBB3-20-AQAQ | 20 (40 μL) | 200 μL |
ERBB3 Gene Summary
This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Gene Name: Erb-b2 Receptor Tyrosine Kinase 3
Chromosome: CHR12: 56473808 -56497291
Locus: 12q13.2
MDK Gene Summary
This gene encodes a member of a small family of secreted growth factors that binds heparin and responds to retinoic acid. The encoded protein promotes cell growth, migration, and angiogenesis, in particular during tumorigenesis. This gene has been targeted as a therapeutic for a variety of different disorders. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Jul 2012]
Gene Name: Midkine
Chromosome: CHR11: 46402617 -46405375
Locus: 11p11.2
Gene Diseases
The MDK ERBB3 Fusion has been associated with the following diseases:
Disease Name |
---|
Lung Squamous Cell Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|